BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37148744)

  • 1. circFANCA accelerates the malignant process of OSCC by modulating miR-34a/PA28γ signaling.
    Ren Y; Pan K; Wang Y; Zhang S; Wang Y; Zhou X; Dan H; Chen Q; Ji N; Li J
    Biochem Biophys Res Commun; 2023 Jul; 665():45-54. PubMed ID: 37148744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
    EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC01123 is associated with prognosis of oral squamous cell carcinoma and involved in tumor progression by sponging miR-34a-5p.
    Qin H; Wang C; Hua Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jan; 133(1):50-59. PubMed ID: 34511356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-34a inhibits the proliferation, migration, and invasion of oral squamous cell carcinoma by directly targeting SATB2.
    Ge X; Gao J; Sun QW; Wang CX; Deng W; Mao GY; Li HQ; Guo SS; Cheng J; Wu YN; Ye JH
    J Cell Physiol; 2020 May; 235(5):4856-4864. PubMed ID: 31663131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma.
    Zhu X; Zhang H; Xu J
    Bioengineered; 2021 Dec; 12(1):3993-4003. PubMed ID: 34282711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
    Wang Y; Jiang Y; Chen L
    J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1.
    Ding J; Sun D; Xie P
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138758
    [No Abstract]   [Full Text] [Related]  

  • 10. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
    Arch Oral Biol; ; . PubMed ID: 33676362
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.